1.89 Remix Therapeutics doses first subjects in Phase I cancer treatment trials

News


<< back

Remix Therapeutics doses first subjects in Phase I cancer treatment trials
Date: 2024-05-03 [news.yahoo.com]

READ THE FULL NEWS >>
×